Rapid acting insulinotropic agents: Restoration of early insulin secretion as a physiologic approach to improve glucose control

Current Pharmaceutical Design

Volumn 7, Issue 14, 2001, Pages 1375-1397

  Pratley, R E ^a   Foley, J E ^a   Dunning, B E ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIMETHYL 2 (2 MORPHOLINOPHENYL)GUANIDINE FUMARATE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; MEGLITINIDE; METFORMIN; MITIGLINIDE; NATEGLINIDE; PLACEBO; REPAGLINIDE; STREPTOZOCIN; SULFONYLUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CULTURE MEDIUM; DOG; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MONKEY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; STREPTOZOCIN DIABETES; VOLUNTEER;

ANIMALS; CARBAMATES; CYCLOHEXANES; DIABETES MELLITUS, TYPE 2; GLUCOSE; GUANIDINES; HUMANS; HYPOGLYCEMIC AGENTS; INDOLES; INSULIN; PHENYLALANINE; PIPERIDINES;

EID: 0034856587     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612013397348     Document Type: Article

References (143)